Importance of A-loop complementarity with tRNA(His )anticodon for continued selection of tRNA(His )as the HIV reverse transcription primer by Ni, Na et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
Virology Journal
Open Access Research
Importance of A-loop complementarity with tRNAHis anticodon for 
continued selection of tRNAHis as the HIV reverse transcription 
primer
Na Ni, Wenqin Xu and Casey D Morrow*
Address: Department of Cell Biology, University of Alabama at Birmingham, Birmingham, AL 35294-0024, USA
Email: Na Ni - niinaa1@uab.edu; Wenqin Xu - wxu@uab.edu; Casey D Morrow* - caseym@uab.edu
* Corresponding author    
Abstract
Background:  Human immunodeficiency virus (HIV-1) preferentially selects tRNALys,3 as the
primer for reverse transcription. HIV-1 can be forced to select alternative tRNAs through mutation
in the primer-binding site (PBS) and a region upstream of the PBS designated as the A-loop.
Alteration of the PBS and A-loop to be complementary to the 3' terminal nucleotides and
anticodon of tRNAHis results in HIV-1 that can stably utilize this tRNA for replication.
Results: In the current study, we have investigated the effect that mutations within the A-loop
have on the stability of HIV-1 with a PBS complementary to tRNAHis. For these studies, we have
altered the A-loop to be complementary to tRNAMet, tRNAGln, tRNAIle, tRNAThr and tRNASer. All
substitutions of the A-loops with the PBS complementary to tRNAHis resulted in a reduction of
infectious virus obtained following transfection of proviral genomes in the 293T cells. Virus
replication in SupT1 cells was also impaired as a result of the alteration of the A-loop. Viruses with
the A-loop complementary to tRNALys,3 and tRNASer reverted to utilize tRNALys,3 following in vitro
replication. In contrast, viruses with the A-loop complementary to the other tRNAs remained
stable and continued to use tRNAHis. RNA modeling of the stem-loop structure revealed that
nucleotides were displayed on the loop region that could potentially interact with the anticodon of
tRNAHis. To further explore the effects of the A-loop mutations on virus replication, the A-loops
complementary to tRNASer or tRNAHis were cloned into the wild type genome with the PBS
complementary to tRNALys,3. Transfection of proviral genomes which contained the wild type PBS
and A-loops complementary to tRNASer or tRNAHis into 293 T cells did not impact on the
production of viruses as measured by p24 antigen ELISA. However, viruses with the A-loop
complementary to tRNAHis  had greatly reduced infectivity and replicated poorly in SupT1
compared to the wild type or viruses with the A-loop complementary to tRNASer.
Conclusion:  These studies demonstrate that complementarity of A-loop region with the
anticodon of tRNAHis has a pronounced effect on the capacity of HIV-1 to utilize tRNAHis as the
primer for reverse transcription. Complementarity between A-loop and anticodon of the tRNA
then is important for the selection of the tRNA primer used for reverse transcription.
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Background
The hallmark of retrovirus replication is the process by
which the RNA genome is converted to a DNA intermedi-
ate prior to integration into the host cell chromosome.
This process, termed reverse transcription is catalyzed by a
virally encoded enzyme reverse transcriptase [1,2]. A cel-
lular tRNA is captured by retroviruses for use as the primer
for the initiation of reverse transcription. The 3' terminal
18-nucleotides of the tRNA is complementary to an 18-
nucleotide region in the viral RNA genome designated as
the primer-binding site (PBS) [3-5]. The reverse tran-
scriptase uses the tRNA bound to the PBS as the primer to
copy the viral genome. During reverse transcription, the
reverse transcriptase copies the tRNA primer to regenerate
the PBS. Thus, the PBS of integrated proviruses is comple-
mentary to the tRNA primer used for initiation [6-8].
Human immunodeficiency virus (HIV-1) preferentially
selects tRNALys,3 as the primer for replication [9-12]. Previ-
ous studies have shown that alteration of the PBS to be
complementary to alternative tRNAs, allows HIV-1 to
transiently utilize these tRNAs for replication [13-15].
However, HIV-1 with the PBS complementary to these
alternative tRNAs revert following in vitro culture to utilize
tRNALys,3. Previous studies from this lab have attempted
to force HIV-1 to utilize alternative tRNAs for replication
[16-20]. To achieve this, mutations have been made in an
upstream region, designated as the A-loop. Previous stud-
ies using both chemical and enzymatic analysis have
shown that the A-loop interacts with the anticodon region
of tRNALys,3 in the initiation complex [21]. Alteration of
the A-loop region to be complementary to certain tRNA
molecules along with mutations in the PBS allow HIV-1 to
utilize certain alternative tRNAs as primer for replication.
Using this approach, we have generated viruses which can
utilize tRNALys1,2, tRNAHis, tRNAGlu, tRNAMet and more
recently tRNAThr [16-19,22,23]. HIV-1 with alterations in
the A-loop and PBS to be complementary to tRNAIle,
tRNASer or tRNAGln though were not stable and rapidly
reverted back to utilize tRNALys,3 following in vitro replica-
tion [20,23,24]. The reason for the preference of HIV-1 for
a certain tRNAs that can be selected and utilized as prim-
ers for replication is unknown. It is possible that primer
selection occurs from an intracellular pool of tRNAs. In
support of this idea, previous studies have shown a link
between primer selection and viral translation [25,26].
One of the more thoroughly characterized HIV-1 that uti-
lizes alternative tRNA is a virus that has been engineered
to replicate using tRNAHis [16,17]. Previous studies from
our laboratory have shown that alteration of the A-loop
and PBS to be complementary to tRNAHis results in a virus
that can stably utilize this tRNA for in vitro replication.
Analysis of virus that had undergone extensive in vitro rep-
lication revealed a RNA stem-loop structure in which the
nucleotides complementary to the anticodon of tRNAHis
were displayed on the loop region. A previous study has
shown that this RNA stem loop structure has the potential
to interact with tRNAHis in vitro [27].
In the current study, we have further explored the specifi-
city of the A-loop in the primer selection process. Since
RNA structure of the A-loop is probably important, we
have used A-loop regions from viruses that have been
engineered to stably utilize alternative tRNAs (tRNAMet
and tRNAThr). We have also used A-loop regions that are
complementary to the anticodon of tRNAIle, or tRNASer or
tRNAGln which are not stably used by HIV-1. The A-loop
regions thus display nucleotides complementary to the
different tRNAs on the loop of an RNA stem-loop. Analy-
sis of the replication and stability of the PBS revealed that
certain A-loops effectively substitute for the A-loop com-
plementary to the anticodon of tRNAHis to allow the virus
to stably utilize this tRNA for replication. The presence of
nucleotides that can interact with the anti-codon of tRNA-
His correlates with the stability of these viruses following in
vitro replication. Alteration of the A-loop region comple-
mentary to the anticodon of tRNAHis can also impact on
the replication of the wild type virus. The results of these
studies demonstrate that the complementarity of the A-
loop region with the anticodon region of tRNAHis  is
important for the stable selection and use of this tRNA as
the primer for reverse transcription.
Results
Construction of HIV-1 with A-loop mutations and PBS 
complementarity to tRNAHis
In previous studies, we have described HIV-1 proviral
genome in which the PBS has been altered to be comple-
mentary to tRNAHis that maintains the A-loop comple-
mentary to tRNALys,3(NL4-His) [16,17]. We have also
previously described proviral genomes in which both the
A-loop and PBS have been made complementary to the
anticodon and 3' terminal nucleotides at tRNAHis (NL4-
His-HisAC). Previous studies have shown that this virus
stably maintains a PBS complementary to tRNAHis follow-
ing replication in SupT1 cells. In the current study, we
have made use of the A-loop regions that are complemen-
tary to tRNAMet, tRNAIle, tRNAGln, tRNASer and tRNAThr.
These A-loop regions were cloned into proviral genomes
in which the PBS was complementary to tRNAHis. The
resulting viruses were named NL4-His-MetAC, NL4-His-
IleAC, NL4-His-GlnAC, NL4-His-SerAC and NL4-His-
ThrAC (Figure 1).
We first analyzed the production of infectious virus fol-
lowing transfection of the proviral genomes into 293T
cells. In general, we found that the amount of virus pro-
duced as determined p24 antigen from the transfection
supernatant was comparable for all of the mutants andVirology Journal 2007, 4:4 http://www.virologyj.com/content/4/1/4
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similar to that of the wild type virus (NL4-WT). Thus,
alteration of the A-loop and PBS did not effect virus pro-
duction as measured by p24 antigen. However, alteration
of the PBS resulted in a reduction in the production of
infectious virus, as determined by the JC53-BL assay, to
levels that were approximately 20% that of the wild type
virus. This result is consistent with previous studies from
our laboratory which have shown that alteration of the
PBS generally results in a reduction production of infec-
tious virus, but not viral proteins, as compared to the wild
type virus.
To determine the effects of the A-loop mutations on the
replication of virus, we analyzed the replication following
culture in SupT1 cells. Infections were established with
the same amounts of infectious virus and was monitored
by the production of viral proteins (p24) in the superna-
tant using the p24 antigen ELISA capture assay. Analysis of
the replication of SupT1 culture infected with the wild
type (NL4-WT) virus revealed a rapid rise in the produc-
tion of p24 antigen in the cultures that peaked at approx-
imately 14 days and was maintained throughout the
duration of the infection (42 days). The virus in which the
PBS was altered to be complementary to tRNAHis (NL4-
His) exhibited a delay in the increase of replication, but
eventually reached a peak level similar to the wild type
virus at Day 28 of culture. In contrast, virus in which the
PBS and A-loop were complementary to tRNAHis (NL4-
HIV-1 proviral genomes with mutated A-loop and PBS Figure 1
HIV-1 proviral genomes with mutated A-loop and PBS. The A-loop (boxed) and PBS (shaded) were altered in the NL4 
proviral clone to be complementary to tRNAHis, tRNAIle, tRNAMet, tRNAThr, tRNASer or tRNAGln. The NL4-WT contains a 
PBS and A-loop complementary to the 3' terminal 18 nucleotides and the anticodon of tRNALys,3. The NL4-His contains a PBS 
complementary to tRNAHis but the A-loop is complementary to the anticodon region of tRNALys,3. The remaining proviral 
clones contain a PBS complementary to tRNAHis with additional mutations in the A-loop to be complementary to the antico-
don of the designated tRNA (e.g. NL4-His-HisAC).
AGTCAGTGTGGAAAATCTCTAGCAGTGGCGCCCGAACAGGGACCTGAAA NL4-WT
AGTCAGTGTGGTACTATCTCTAGCAATGGTGCCGTGACTCGGATCTGAAA
AGTCAGTGTGGTTCTATCTCTAGCAATGGTGCCGTGACTCGGATCTGAAA
AGTCAGTGTGGGAAAATCTCTAGCAGTGGTGCCGTGACTCGGATCTGAAA NL4-His
AGTCAGTGTGCCACAACGCTAGCAATGGTGCCGTGACTCGGATCTGAAA
AGTCAGTGTGCATAAACGCTAGCAATGGTGCCGTGACTCGGATCTGAAA NL4-His-IleAC
AGTCAGTGTGCATGAACGCTAGCAATGGTGCCGTGACTCGGATCTGAAA
AGTCAGTGTGCCAAAACGCTAGCAATGGTGCCGTGACTCGGATCTGAAA
A-loop PBS
NL4-His-ThrAC
NL4-His-SerAC
NL4-His-HisAC
NL4-His-MetAC
NL4-His-GlnACVirology Journal 2007, 4:4 http://www.virologyj.com/content/4/1/4
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His-HisAC), exhibited a substantial delay in replication of
virus reaching a peak only at Day 35 of culture (Figure
2A). Consistent with our previous studies, analysis of the
PBS of these viruses revealed that the PBS of NL4-His had
reverted back to utilize tRNALys,3; this reversion occurred
by approximately Day 28 post initiation of culture when
we observed the rise in p24 antigen in the culture super-
natant. In contrast, NL4-His-HisAC retained a PBS com-
plementary to tRNAHis for the duration of the culture.
We next compared the replication of viruses in which the
PBS was complementary to tRNAHis with different A-loop
combinations. In the first of experiments, we analyzed the
replication of NL4-His-SerAC, NL4-His-IleAC and NL4-
His-GlnAC. Previous studies have shown that viruses with
the U5-PBS complementary to these tRNAs (tRNASer,
tRNAIle and tRNAGln) were unstable and reverted to tRNA-
Lys,3 during culture [24,28]. The replication of NL4-His-
SerAC was delayed compared to that of the wild type
virus, eventually reaching a peak level at Day 35 post ini-
tiation of culture. The viruses derived from NL4-His-
GlnAC and NL4-His-IleAC also exhibited a delay in repli-
cation reaching a peak at a similar time approximately 42
days post initiation of culture (Figure 2B). Analysis of the
PBS of these viruses revealed that NL4-His-SerAC had
reverted to utilize tRNALys,3. In contrast, viruses derived
from NL4-His-GlnAC and NL4-His-IleAC retained the
PBS complementary to tRNAHis for the duration of the cul-
ture. Finally, we analyzed the replication of viruses in
which the A-loop had been mutated to be complementary
to tRNAMet or tRNAThr; previous studies have shown that
U5-PBS complementary to these tRNAs remain stable fol-
lowing in vitro replication [18]. All of these viruses exhib-
ited a delayed replication compared to the wild type virus.
It was only during the end of the culture period (approxi-
mately 30–42 days) that these viruses reached peak levels
of p24 antigen in the culture (Figure 2C). However, anal-
ysis of the PBS of these viruses revealed that all had
retained the PBS complementary to tRNAHis, indicating a
stable use of this tRNA as the primer for replication.
The results from the growth and stability of PBS with the
different A-loop regions were somewhat surprising. Two
viruses, NL4-His and NL4-His-SerAC grew well but the
PBS was unstable and reverted back to utilize tRNALys,3. In
contrast, the viruses with a PBS complementary to tRNAHis
containing different A-loops grew slower but maintained
a PBS complementary to tRNAHis. Particularly surprising
in this group was the virus NL4-His-IleAC and NL4-His-
GlnAC which grew slowly and maintained a PBS comple-
mentary to tRNAHis, since previous studies have shown
that viruses in which both the PBS and A-loop were com-
plementary to tRNAIle or tRNAGln rapidly reverted back to
utilize tRNALys,3 following in vitro replication [18]. We had
suspected that NL4-His-IleAC and NL4-HisGlnAC would
have phenotypes similar to that of NL4-His-SerAC and
revert back to utilize tRNALys,3 following replication. To
gain further insights into this result, we analyzed the
potential RNA structure of the U5 A-loop regions using
mfold. The mfold of the U5-PBS from NL4 revealed a RNA
stem-loop structure in which the A-loop region was dis-
played on the loop. Similarly, the mfold of NL4-His-HisAC
also revealed a RNA stem-loop structure in which the anti-
codons complementary to the tRNAHis were displayed on
the loop of the RNA stem-loop (Figure 3). We next com-
pared the mfolds of NL4-His-SerAC and NL4-His-IleAC. In
the case of NL4-His-SerAC, as expected a nucleotide
sequence was displayed on the loop that was complemen-
tary to tRNASer. Similarly, the mfold of NL4-His-IleAC also
displayed a nucleotide sequence complementary to the
anticodon of tRNAIle. However, we found that the nucle-
otides displayed on the loop of NL4-His-IleAC could also
base pair with the anticodon region of tRNAHis, which was
not the case for the loop region from NL4-His-SerAC. A
similar analysis of the additional viruses revealed the pres-
ence in the loop region of nucleotides that could base pair
with tRNAHis; this also included NL4-His-GlnAC, where
nucleotides within the anticodon loop (not the three
nucleotides of the anticodon) could base pair. Thus, the
stability of the PBS complementary to tRNAHis correlated,
in part, with the presence of nucleotides in the loop com-
plementary to the anticodon of tRNAHis.
Effect of A-loop alteration on replication of wild type virus
To further analyze the effects of the alteration of the A-
loop region on virus replication, we constructed HIV-1
proviruses with a PBS complementary to tRNALys,3 and an
A-loop complementary to either tRNASer or tRNAHis (Fig-
ure 4A). We first analyzed the production of viruses fol-
lowing transfection into 293T cells (Figure 4B). Viruses
derived from transfection of the wild type (NL4-WT) and
viruses with the A-loop complementary to tRNASer (NL4-
WT-SerAC) or tRNAHis (NL4-WT-HisAC) all gave similar
amounts of p24 antigen following transfection. Alteration
of the A-loop region then did not impact substantially on
the production of viral proteins, consistent with our pre-
vious results. We next analyzed the supernatants for infec-
tious virus using the JC53-BL assay. Viruses derived from
NL4-WT-SerAC were slightly less infectious than the wild
type virus. In contrast, we observed substantially reduced
production of infectious virus following transfection of
NL4-WT-HisAC, indicating a pronounced effect of the
alteration of the A-loop to be complementary to tRNAHis.
Interestingly, analysis of the infectious virus produced
from transfection of NL4-His-HisAC revealed the amount
was approximately 4 – 5 times greater than that obtained
from NL4-HisAC, indicating that the preference for HIV-1
to select tRNAHis can be strongly influenced by the inclu-
sion of the A-loop complementary to tRNAHis (Figure 4C).Virology Journal 2007, 4:4 http://www.virologyj.com/content/4/1/4
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Replication of HIV-1 with wild type and altered U5-PBS in SupT1 cells Figure 2
Replication of HIV-1 with wild type and altered U5-PBS in SupT1 cells. Panel A. Replication of HIV (NL4-WT) and 
HIV which contain U5-PBS complementary to tRNAHis. Infections were initiated with equal amounts of infectious virus as 
determined by the JC53-BL assay. Virus replication in SupT1 cells was monitored over 42 days of culture. The amount of virus 
produced was analyzed by p24 ELISA. The identity of the viruses are as marked. Panel B. Comparison of the replication of the 
wild type virus with mutant viruses containing PBS complementary to tRNAHis with different A-loop regions. The identity of 
the viruses are as marked. Panel C. Comparison of the replication of the wild type virus with HIV-1 genomes with the PBS 
complementary to tRNAHis with different A-loop regions. The identity of the viruses are as marked.
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Potential interaction between the anticodon region of tRNAHis and HIV-1 proviral genomes with mutated A-loop regions Figure 3
Potential interaction between the anticodon region of tRNAHis and HIV-1 proviral genomes with mutated A-
loop regions. The A-loop PBS region of NL4-His-HisAC depicting the nucleotides displayed on the loop of an RNA stem loop 
that are complementary to the anticodon of tRNAHis. In the case of NL4-His-HisAC, complete complementarity is noted con-
sisting of eight consecutive nucleotides. Viruses in which the PBS complementary to tRNAHis were unstable following in vitro 
replication included those derived from NL4-His and NL4-His-SerAC (bolded, unstable). Interactions between the anticodon 
of tRNAHis and NL4-His or NL4-His-SerAC consisted of two potential base pair interactions (shaded). In contrast, interaction 
between the anticodon of tRNAHis and viruses which stably maintained a PBS complementary to tRNAHis (NL4-His-IleAC, 
NL4-His-MetAC or NL4-His-ThrAC) revealed three potential base pair interactions (shaded). The virus NL4-GlnAC was also 
stable following in vitro replication. A three-nucleotide interaction could be postulated (in shaded regions) consist of two of the 
three nucleotides in the anticodon of tRNAHis. This putative interaction is denoted with a question mark.
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Analysis of HIV-1 viruses with a wild type PBS complementary to tRNALys,3 with mutated A-loop regions Figure 4
Analysis of HIV-1 viruses with a wild type PBS complementary to tRNALys,3 with mutated A-loop regions. 
Panel A. HIV-1 proviral genomes with the wild type PBS and A-loop (NL4-WT), wild type PBS and A-loop regions mutated to 
be complementary to tRNAHis (NL4-WT-HisAC) or tRNASer (NL4-WT-SerAC). Additional proviral constructs included HIV 
genomes with a PBS and A-loop region complementary to tRNAHis (NL4-His-HisAC). Panel B. Production of virus following 
transfection of wild type and mutant proviral genomes. 293T cells were transfected with equal amounts of proviral genomes 
and the amount of virus released into the supernatant was determined by p24 antigen capture ELISA. All viruses had similar 
amounts of p24 antigen into the culture supernatant (representative of three transfections). Panel C. Infectious virus was pro-
duced following transfection. Viruses were transfected with equal amounts of proviral genomes and the amount of infectious 
virus determined by the JC53-BL assay. Results are the average of the three determinations of infectivity in JC53-BL cells. 
Panel D. Replication of HIV-1 proviral genomes in SupT1 cells. Infections were established with equal amounts of infectious 
virus as determined by the JC53-BL assay. The amount of infectious virus was determined by the p24 antigen capture assay. 
The identity of the viruses are as marked.
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We next compared the replication of theses viruses in
SupT1 cells (Figure 4D). In the case of the wild type virus
(NL4-WT), a rapid increase in the production of infectious
virus, peaking at approximately Day 14 to 21-post initia-
tion of culture. The virus derived from NL4-SerAC gave a
similar replication profile peaking again at Day 14 to 21.
In contrast, virus derived from NL4-HisAC was poorly
infectious during the culture period examined barely pro-
ducing enough virus to be detected using the p24 ELISA.
In fact, replication of NL4-His-HisAC was approximately
100 fold greater than NL4-HisAC (as determined by p24
antigen in the culture supernatant), indicating the A-loop
modification with change in the PBS to be complemen-
tary to tRNAHis facilitated selection and use of tRNAHis as
the replication primer.
Discussion
Previous studies from this laboratory have utilized a
genetic approach to understand the mechanism of primer
selection by HIV-1 [16-20,22]. Alteration of both the A-
loop region and PBS to be complementary to several dif-
ferent tRNAs resulted in HIV-1 having the capacity to sta-
bly utilize these tRNAs for replication. Viruses which can
utilize tRNAHis, tRNAMet, or tRNAThr have been previously
described [16-18,23]. All of these viruses maintain the
PBS complementary to the cognate tRNA, although their
replication is diminished compared to the wild type. In
contrast, the viruses in which PBS and A-loop were com-
plementary to tRNAIle, tRNASer, or tRNAGln did not utilize
these tRNAs following in vitro culture, and rapidly reverted
to utilize tRNALys,3 [20,23,24]. It was not clear though,
from our previous studies if the nucleotide sequence
within the A-loop region and the RNA structure of this A-
loop region were important for the virus to maintain a
PBS to an alternative tRNA. The results of our current
study highlight the importance of the nucleotide sequence
displayed on the A-loop region for the unique selection of
tRNAHis as the primer for replication. Only those viruses in
which the A-loop region contained nucleotides that could
interact with the anticodon region of tRNAHis stably main-
tained the PBS complementary to tRNAHis following repli-
cation. Indeed, even viruses NL4-His-IleAC and NL4-His-
GlnAC stably maintained a PBS complementary to tRNA-
His following in vitro replication. Viruses in which the PBS
and A-loop region were complementary to tRNAIle or
tRNAGln though rapidly reverted to utilize tRNALys,3 fol-
lowing in vitro replication [20,23,24]. One explanation for
this discrepancy is that the availability of tRNAHis, tRNAIle
and tRNAGln could differ for selection as primers for HIV-
1 reverse transcription. We would expect that if tRNAIle or
tRNAGln were available for primer selection, it would com-
pete with tRNAHis for interaction with the A-loop region
which could potentially compromise the stability of the
PBS following in vitro replication. The stability of the A-
loop regions complementary to tRNAMet and tRNAThr that
allow the virus to stably utilize tRNAHis might mean that
tRNAHis has a greater intracellular availability for primer
selection. This explanation will also account for the results
obtained with the virus NL4-His-SerAC, which contained
nucleotides displayed on the loop region that are comple-
mentary to the anticodon of tRNASer. This virus rapidly
reverted to utilize tRNALys,3 following in vitro replication.
Without tRNASer available to interact with the A-loop, and
because the nucleotides in the A-loop of NL4-His-SerAC
are not complementary to the anticodon of tRNAHis, tRN-
ALys,3 would be favored for capture, leading to the conver-
sion of the PBS to be complementary to tRNALys,3.
The results of our studies support the idea that A-loop
region plays an important role in the selection of tRNAHis
as an alternative primer for HIV-1 replication [16,17]. Pre-
vious studies have utilized in vitro systems to demonstrate
that the A-loop region does interact with the anticodon of
tRNAHis [27]. The results of our current studies again sup-
port that this interaction is important for the continued
selection of tRNAHis as the primer for reverse transcrip-
tion. A surprising result from our studies was the impact
of the A-loop region complementary to tRNAHis on the
replication of the wild type virus with the PBS comple-
mentary to tRNALys,3 (NL4-WT-HisAC). In fact, NL4-WT-
HisAC replicated poorly compared to the wild type virus
or NL4-WT-Ser which contained the A-loop region com-
plementary to tRNASer. This inhibition of replication was
not due to production of virus as demonstrated following
transfection of proviral genomes in the 293T cells where
we recovered similar amounts of p24 antigen in the cul-
ture supernatants. Rather, the major effect was on the pro-
duction of infectious virus as determined both by the
JC53-BL assay and from analysis of virus replication stud-
ies in SupT1 cells. How the A-loop complementary to the
anti-codon would inhibit replication of the virus with a
PBS complementary to tRNALys,3 is unclear. One possibil-
ity could be that because of the availability of tRNAHis, the
A-loop attracts tRNAHis to the U5-PBS. The presence of
both tRNAHis and tRNALys,3 with the U5-PBS could inter-
fere with primer selection, accounting for the lower pro-
duction of infectious virus.
Conclusion
In the current study, we have further investigated the
mechanism of HIV-1 primer selection using a unique
virus which has been engineered to use tRNAHis as the
primer for replication. For HIV-1 to select tRNAHis as the
primer, previous studies have found that additional muta-
tions were required in the A-loop region upstream of the
PBS to be complementary to the anticodon of tRNAHis
[16,17]. Viruses in which the A-loop region contains
nucleotides complementary to the anticodon of tRNAHis
stably maintained the PBS complementary to tRNAHis fol-
lowing in vitro replication. In contrast, viruses which theVirology Journal 2007, 4:4 http://www.virologyj.com/content/4/1/4
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A-loop contained nucleotides that could not interact with
the anticodon of tRNAHis (NL4-His-SerAC or NL4-His)
reverted to utilize tRNALys,3 following a short-term in vitro
culture. Substitution of the A-loop in the wild type
genome to be complementary to the anticodon of tRNAHis
rather than tRNALys,3 had a profound impact on virus rep-
lication.
Our results are consistent with the idea that there is an
interaction between the tRNA and A-loop region and PBS
could facilitate the selection of the primer. If the A-loop
region is complementary to alternative tRNAs that are
available (e.g. tRNAHis), this interaction could interfere
with the efficient selection of tRNALys,3. A previous study
described several alternative RNA structures in the 5' NTR
that could function as a riboswitch for dimerization and
encapsidation [29]. When considered in the context of the
results presented in this study, it is possible that the RNA
structures could be involved in the selection of the tRNA
primer through interaction with the A-loop and PBS.
Many riboswitch elements have been identified in the 5'
NTR of bacterial RNAs including T-box RNAs which inter-
act with tRNAs [30-33]. It is possible that the process of
primer selection/capture could involve a riboswitch like
mechanism in which the A-loop-PBS co-ordinates the
capture of available tRNAs, such as tRNAHis, tRNAMet,
tRNAThr and of course tRNALys,3. Additional experiments
will be needed to delineate the important features of the
interaction between the U5-PBS and tRNA that are
involved in primer selection.
Materials and methods
Construction of mutant proviral genomes
All mutations were made in pUC119PBS or derivatives
using the Quick change II site-directed mutagenesis kit
(Stratagene, LaJolla, CA). The pUCHis-SerAC, pUCHis-
ThrAC, pUCHis-IleAC, pUCHis-MetAC, pUCHis-GlnAC
are the mutants with PBS complementary to tRNAHis
while A-loop complementary to the anticodon of tRNASer,
tRNAThr, tRNAIle, tRNAMet and tRNAGln respectively. For all
these pUCHis mutants, the modifications in A-Loop were
made with pUC119HisAC as the template. In
pUC119HisAC, both PBS and A-Loop are pared with
tRNAHis. The primers for pUC119His-SerAC were 5'-
GACCCTTTTAGTCAGTGTGCTTCTAACGCTAGCAAT
GGTGC-3' (sense) and 5'-GCACCATTGCTAGCGTTA-
GAAGCACACTGACTAAAA GGGTC-3' (anti-sense); the
primers for pUC119His-ThrAC were 5'-GACCCTTTTAGT
CAGTGTGCTACAAACGCTAGCAATGGTGC-3' (sense)
and 5'-GCACCATTGCTA GCGTTTGTAGCACACT-
GACTAAAAGGGTC-3' (anti-sense); the primers for
pUC119His-IleAC were 5'-GACCCTTTTAGTCAGTGT-
GCATAAACGCTAGCAATG GTGCC-3' (sense) and 5'-
GGCACCATTGCTAGCGTTTATGCACACTGACTAAAA
GGGTC-3' (anti-sense); the primers for pUC119His-
MetAC were 5'-GACCCTTTTAG TCAGTGTGCAT-
GAACGCTAGCAATGGTGCC-3' (sense) and 5'-GGCAC-
CATTGC TAGCGTTCATGCACACTGACTAAAAGGGTC-3'
(anti-sense) and the primers for pUC119His-GlnAC were
5'-GACCCTTTTAGTCAGTGTGCCAAAACGCTAGCAAT
GGTGC-3' (sense) and 5'-GCACCATTGCTAGCGTTTT-
GGCACACTGACTAAAAG GGTC-3' (anti-sense). To con-
struct the mutants with wild type PBS and altered A-loop
regions, the starting plasmid was pUC119PBS. To con-
struct HIV-1 with the A-loop to be complementary to
tRNAHis with PBS complementary to tRNALys,3, the three
additional nucleotides 628, 635, 654 were changed to the
G, A and C, because these three mutations have been
shown to facilitate the usage of tRNAHis together with A-
loop mutations [17,27]. The site-directed mutagenesis
was carried out on the plasmid pUC-119 vector that has
wild type PBS. The synthetic oligonucleotides primers to
construct pUC-WT-HisAC were 5'-
GTCAGTGTGGAAAATCGCTAGCAATGGCGCCCGAACAG-
GGACCTGA AAGCGAAAGGGAAAC-3' (sense) and 5'-GTTTC-
CCTTTCGCTTTCAGGTCCCTGT
TCGGGCGCCATTGCTAGCGATTTTCCACACTGAC-3' (anti-
sense). Following the mutagenesis, the clones were con-
firmed by DNA sequencing. All the pUC119 mutants were
digested with HpaI and BssHII and inserted into SmaI and
BssHII sites of NL4-3 HIV-1 proviral plasmid. The result-
ing NL4-3 mutants were verified by the automated DNA
sequencing.
Tissue culture
The 293T cells were maintained in Dulbecco's modified
Eagle's medium (DMEM) (Cellgro, Hemdon, VA) plus
10% fetal bovine serum (FBS) (Hyclone, Logan UT) and
1% antibiotic-antimycotic (Bibco BRL, Rockville, MD).
SupT1 cells were maintained in RPMI 1640 (Cellgro,
Hemdon, VA), supplemented with 15% FBS and 1% anti-
biotic-antimycotic.
DNA transfections
Transfections were performed according to the protocol of
Fugene 6 transfection Reagent (Roche Molecular Bio-
chemicals, Indianapolis, IN). 3 ul Fugene reagent was
added to 100 ul of DMEM without FBS, the 2 ug of provi-
ral plasmid DNA was added 5 minutes later. The mixture
was incubated at room temperature for 45 minutes then
added to one well of a 6-well plate with 40% confluent
293T cells in DMEM with 10% FBS. The transfections were
incubated at 37°C for 72 hours, then the supernatants
were collected and centrifuged with 24,000 × g for 1
minute. The supernatants were aliquoted and stored at -
80°C. The p24 antigen of the supernatants was analyzed
by ELISA (Beckman Coulter, Miami, FL) and infectivity
was determined by JC53-BL assay as described previously.Virology Journal 2007, 4:4 http://www.virologyj.com/content/4/1/4
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Infection of SupT1 and virus replication
The viral supernatants with 1000IU infectivity were used
to infect 1 × 106 SupT1 cells. The mixture of virus and
SupT1 cells were incubated at 37°C for 4 hours, shaking
every 30 minutes. The mixtures were then transferred to
25 cm2 tissue culture flasks and the final volumes were
adjusted to 10 mL by RPMI 1640 plus 15% FBS and 1%
antibiotic-antimycotic.
The infected SupT1 cells were passaged at 1:4 every 3 days.
When the cells were cleared because of syncytia, the fresh
1 × 106 SupT1 cells were added to all cultures. Every 7
days, 1 mL of cell culture was collected and centrifuged at
24,000 × g for 1 minute. The supernatant and cell pellets
were store at -80°C for further analysis.
DNA sequencing of viral U5-PBS region
High-molecular-Weight DNA (HWM) was extracted from
infected SupT1 cell pellets by Wizard genomic DNA puri-
fication kit (Promega, Madison, WI) following the proto-
col. The fragment containing U5-PBS region was
amplified from HMW by PCR with primers EcoRI  (5'-
CGGAATTCTCTCTCCTTCTAGCCTCCGCTAGTC-3') and
SphI  (5'-CCTTGAGCATGCGATCTACCACACACAAGGC-
3'). The resulting PCR products were run on 1% agarose
gel and the amplified fragments were cut and purified
with the Qiagen Gel Purification kit (Qiagen, Valencia,
CA). The sequence of purified DNA was determined by
automated DNA sequencing with EcoRI as primer.
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